Delisting riskPopularity #3,538
PDSB · NASDAQ · Biotechnology

PDS Biotechnology (PDSB)

Develops investigational immunotherapies for cancer and infectious diseases.

$0.8532
vs last close−0.06 (−6.24%)
  1. PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why

    Zacks Investment Research